Key result
Alvimopan permits accelerated return of bowel function after abdominal surgery in select patients and has the potential to improve clinical and financial results.
Why the study?
Does alvimopan accelerate the return of bowel function in patients undergoing abdominal surgery?
Does alvimopan accelerate the return of bowel function in patients undergoing abdominal surgery?
Alvimopan is a tool that can accelerate the return of bowel function and potentially improve clinical and financial outcomes after abdominal surgery.
May support alvimopan for faster bowel recovery in select patients; leaves open need for RCTs before routine use.
Postoperative ileus negatively impacts patient outcomes and healthcare utilization, increasing both postoperative length of stay and health care costs. In efforts to optimize perioperative care, efforts have been placed into developing tools to minimize postoperative ileus. Alvimopan (Entereg®) was developed to meet this need. Alvimopan has permitted accelerated return of bowel function after abdominal surgery in select patients. Alvimopan has the potential to significantly improve clinical and financial results, and research is ongoing to determine effective further applications of this medication.
No takes yet. Share an insight, caveat, or question.
Crawshaw et al. (2014) conducted a review in Postoperative ileus in colorectal surgery. Alvimopan was evaluated. Alvimopan permits accelerated return of bowel function after abdominal surgery in select patients and has the potential to improve clinical and financial results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: